Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 10 March 2022




Pharmaceutical industry response to the war in Ukraine
10 March 2022

Supporting people affected by the war Read more

Improving cancer screening to help beating cancer
09 March 2022

For cancer patients, early diagnosis is a key determinant of timely treatment and survival outcomes. Read more




Can inclusive innovation help #BreakTheBias? (Guest blog)
08 March 2022 - Kees Roks

To deliver better science, smarter innovation, and better outcomes – we need more women at the table, presenting their... Read more

How can we make the joint EU HTA more than just a sum of the currently fragmented national...
08 March 2022 - Ansgar Hebborn

During the discussions in Paris, it was evident that the EU HTA regulation will only deliver against its promise, if... Read more


Let's back innovation in Europe


Where innovation happens, matters
For patients, for healthcare systems, for our academic, SME and research communities, for jobs, for the economy. Read more

Innovate or stagnate
As a region we can chose to innovate or stagnate, and if innovation happens elsewhere then high value, highly skilled... Read more




The shake-up of orphan and pediatric rules
17 March 2022 (Virtual event)

Organised in partnership with POLITICO Read more

DIA Europe 2022
29 March 2022 (Hybrid conference (virtual - Brussels))

Advancing Health Priorities Read more


What we are reading


EU pandemic strategy tries to bridge drug companies and civil society
On 28 February 2022 (Financial Times)

“If we get it right" says Nathalie Moll, "and the pharma legislation review has all the right policy instruments and... Read more

IP in the EU FTA’s Series: The Link Between IP and Industrial Policy
On 09 March 2022 (ECIPE)

With Luisa Santos, Deputy Director General at BusinessEurope. Read more